Neuland Lab Consolidated June 2021 Net Sales at Rs 200.89 crore, down 2.21% Y-o-Y
NULL03-08-2021
Earnings Call for Q1FY22 of Neuland Laboratories
Conference Call with Neuland Laboratories Management and Analysts on Q1FY22 Performance and Outlook. Listen to the full earnings transcript.03-08-2021
Neuland Laboratories Ltd - 524558 - Unaudited Financial Results For June 30, 2021 Along With Press Release And Investor Presentation
Unaudited Financial Results For June 30, 2021 along with Press Release and Investor Presentation03-08-2021
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For June 30, 2021 Along With Press Release And Investor Presentation
Unaudited Financial Results For June 30, 2021 along with Press Release and Investor Presentation03-08-2021
Neuland Laboratories Ltd - 524558 - Announcement under Regulation 30 (LODR)-Meeting Updates
We refer to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 and enclose a copy of the Q1 FY 2021-2022 Earnings Call details, for your information and records.29-07-2021
Neuland Laboratories Ltd - 524558 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results For The Quarter Ended June 30, 2021
NEULAND LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2021 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2021.16-07-2021
NEULAND LABORATORIES LTD. - 524558 - Shareholding for the Period Ended June 30, 2021
Neuland Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here12-07-2021
Neuland Laboratories Ltd - 524558 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Neuland Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here08-07-2021
Neuland Laboratories Ltd - 524558 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Sarada BhamidipatiDesignation :- Company Secretary and Compliance Officer08-07-2021
Neuland Laboratories Ltd - 524558 - Updated Annual Report For FY 2020-21
Updated Annual Report for FY 2020-2108-07-2021